Content Conference Coverage Conferences IDWeek 2015
Coverage of IDWeek 2017
- Details
- Category: HIV Treatment
- Created on Thursday, 30 November 2017 00:00
HIVandHepatitis.com coverage of IDWeek 2017, held October 4-8, 2017, in San Diego.
- Long-Acting Monoclonal Antibody Effective Against Multidrug-Resistant HIV
- Single-Tablet Protease Inhibitor Regimen Maintains Viral Suppression for a Year
11/30/17
Coverage of IDWeek 2016
- Details
- Category: HIV Treatment
- Created on Friday, 04 November 2016 00:00
HIVandHepatitis.com coverage of IDWeek 2016, held October 26-30 in New Orleans.
Conference highlights include experimental HIV therapies, PrEP and other biomedical HIV prevention, antibiotic resistance, and emerging infectious diseases such as Ebola virus and Zika virus.
Full listing of coverage by topic
11/4/16
IDWeek 2015 Features HIV and Hepatitis C Prevention, Treatment, and Cure Research
- Details
- Category: HIV Treatment
- Created on Wednesday, 07 October 2015 00:00
Immediate antiretroviral therapy is the big HIV news of the year and interferon-free therapy has transformed the treatment of hepatitis C despite its high cost, experts said during an overview of "What's Hot" in the field, presented at the IDWeek 2015 conference taking place this week in San Diego. Participants also heard a keynote talk by Ian Crozier, a doctor who survived Ebola virus disease.
IDWeek 2015: Affordable Care Act Coverage Improves Chances of HIV Viral Suppression
- Details
- Category: HIV Treatment
- Created on Thursday, 08 October 2015 00:00
Enrolling low-income and under-insured people with HIV in an Affordable Care Act (ACA) health plan improves their odds of having sustained antiretroviral treatment and undetectable viral load, according to a presentation at ID Week 2015 in San Diego. This study adds to the recent evidence confirming the benefits of providing healthcare coverage for people living with HIV.
Coverage of IDWeek 2015
- Details
- Category: HIV Treatment
- Created on Friday, 09 October 2015 00:00
HIVandHepatitis.com coverage of IDWeek 2015, October 7-11 in San Diego.
Conference highlights include new HIV therapies and treatment strategies, HIV and hepatitis C continuums of care, and comorbidities among people with HIV and HIV/HCV coinfection, as well as news about antibiotic stewardship and other infectious diseases including Ebola virus.
Full listing of coverage by topic
10/9/15
More Articles...
- IDWeek 2015: Studies Continue to Support Tenofovir Alafenamide as it Nears Approval
- IDWeek 2015: HIV Attachment Inhibitor BMS-663068 Matches Atazanavir in Phase 2b Study
- IDWeek 2015: Post-Treatment Control of HIV Appears Rare, Biomarkers May Help Predict Rebound
- IDWeek 2015: Many People with HIV Are Not Virally Suppressed on Antiretroviral Therapy
- IDWeek 2015: Emergency Needle Exchange Reduces HIV and HCV Risk in Indiana
- IDWeek 2015: HIV/HCV Coinfected People Achieve High Cure Rates with Grazoprevir/Elbasvir
- IDWeek 2015: Hepatitis C Mortality Continues to Increase in the U.S.
- IDWeek 2015: Sofosbuvir + Daclatasvir Demonstrates High Cure Rates for HIV/HCV Coinfected People
Web Design and Development by